Fluorescence-based Western blotting for quantitation of protein biomarkers in clinical samples.
Since most high throughput techniques used in biomarker discovery are very time and cost intensive, highly specific and quantitative analytical alternative application methods are needed for the routine analysis. Conventional Western blotting allows detection of specific proteins to the level of single isotypes while its quantitative accuracy is rather limited. We report a novel and improved quantitative Western blotting method. The use of fluorescently labelled secondary antibodies strongly extends the dynamic range of the quantitation and improves the correlation with the protein amount (r=0.997). By an additional fluorescent staining of all proteins immediately after their transfer to the blot membrane, it is possible to visualise simultaneously the antibody binding and the total protein profile. This allows for an accurate correction for protein load. Applying this normalisation it could be demonstrated that fluorescence-based Western blotting is able to reproduce a quantitative analysis of two specific proteins in blood platelet samples from 44 subjects with different diseases as initially conducted by 2D-DIGE. These results show that the proposed fluorescence-based Western blotting is an adequate application technique for biomarker quantitation and suggest possibilities of employment that go far beyond.
Zellner
Maria
M
Department of Surgery, Medical University of Vienna, Vienna, Austria.
Babeluk
Rita
R
Diestinger
Michael
M
Pirchegger
Petra
P
Skeledzic
Senada
S
Oehler
Rudolf
R
D015415:Biomarkers / Q000032:analysis*; D015153:Blotting, Western / Q000379:methods*; D005453:Fluorescence; D006801:Humans; D008875:Middle Aged; D011506:Proteins / Q000032:analysis*
D015415:Biomarkers; D011506:Proteins